(Q39578882)

13 September 2017

Induction of apoptosis by metformin in epithelial ovarian cancer: involvement of the Bcl-2 family proteins (English)

1 reference

13 September 2017

1 reference

1 reference

1 reference

Amber Yasmeen

1

1 reference

13 September 2017

Marie-Claude Beauchamp

2

1 reference

13 September 2017

Ettie Piura

3

1 reference

13 September 2017

Eric Segal

4

1 reference

13 September 2017

Michael Pollak

5

1 reference

13 September 2017

Walter H Gotlieb

6

1 reference

13 September 2017

language of work or name

English

0 references

publication date

8 March 2011

1 reference

13 September 2017

1 reference

13 September 2017

121

1 reference

13 September 2017

3

1 reference

13 September 2017

492-498

1 reference

13 September 2017

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.021

Molecular pathogenesis and therapeutic targets in epithelial ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.021

Current management strategies for ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.021

Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.021

Metformin and reduced risk of cancer in diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.021

New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.021

Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.021

The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.021

Role of AMP-activated protein kinase in mechanism of metformin action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.021

Cancer therapy: staying current with AMPK.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.021

Targeting AMPK: a new therapeutic opportunity in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.021

AMP-activated protein kinase and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.021

In vitro metformin anti-neoplastic activity in epithelial ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.021

Bcl2 family proteins in carcinogenesis and the treatment of cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.021

Bcl-2 family proteins and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.021

The prognostic importance of p53, bcl-2, and bax in early stage epithelial ovarian carcinoma treated with adjuvant chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.021

Increased bcl-2 expression is associated with primary resistance to chemotherapy in human epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.021

Urinary levels of Bcl-2 are elevated in ovarian cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.021

Does ovarian cancer treatment and survival differ by the specialty providing chemotherapy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.021

Ovarian cancer: a focus on management of recurrent disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.021

Age-associated elevation of hypothalamic, threshold to feedback control, and its role in development, ageine, and disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.021

The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.021

Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.021

Metformin induces apoptosis of pancreatic cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.021

Metformin induces unique biological and molecular responses in triple negative breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.021

Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.021

Dual antiglioma action of metformin: cell cycle arrest and mitochondria-dependent apoptosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.021

Metformin is a potent inhibitor of endometrial cancer cell proliferation--implications for a novel treatment strategy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.021

Polymorphism in human organic cation transporters and metformin action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.021

Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.021

The Bcl-2 protein family: arbiters of cell survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.021

Metformin and cancer: doses, mechanisms and the dandelion and hormetic phenomena

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.021

Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.021

Criteria for analyzing interactions between biologically active agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.021

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YGYNO.2011.02.021

1 reference

13 September 2017

1 reference